<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="45214">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01895426</url>
  </required_header>
  <id_info>
    <org_study_id>AAG-O-H-1227</org_study_id>
    <nct_id>NCT01895426</nct_id>
  </id_info>
  <brief_title>ArcadiusXP L Post Market Clinical Follow-Up</brief_title>
  <acronym>ArcadiusXPLPMS</acronym>
  <official_title>Clinical Follow-up of the ArcadiusXP L Stand Alone Intervertebral Body Fusion Device</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Aesculap AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Aesculap AG</source>
  <oversight_info>
    <authority>Germany: Ethics Commission</authority>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to collect clinical and radiological mid-term (2 years) data on
      the ArcadiusXP L® lumbar stand-alone cage in a post-market clinical follow-up study (PMCF)
      limited to 32 patients.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>April 2013</start_date>
  <completion_date type="Anticipated">February 2017</completion_date>
  <primary_completion_date type="Anticipated">February 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case-Only, Time Perspective: Prospective</study_design>
  <primary_outcome>
    <measure>ODI (2y) - ODI(preop)</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Difference between Oswestry Disability Index (ODI) at 2 years and preoperative ODI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Fusion/arthrodesis status, and further radiological documentation of operated and adjacent levels</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Angle difference in flexion and extension radiographs at each timepoint; analysis of AP and ML x-rays regarding changes in bone density (identification of bone bridges): CT/MRT are considered when available; consideration of pot. radiolucencies around the</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall success</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>ODI at each timepoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall success</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Improvement of at least 15 points in the Oswestry Disability Index score compared to the baseline score;
No device failures requiring revision, reoperation, or removal;
Absence of major complications, defined as major vessel injury or major neurological deterioration (e.g., nerve root injury);
Maintenance or improvement in neurological status vs. baseline, with no permanent neurological deficits compared to baseline status.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain (back and leg)</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Pain levels (back and leg) as measured via Visual Analogue scale (VAS) at each timepoint</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Adverse events</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient satisfaction</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>&quot;Would you have the Operation again?&quot;</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Concomitant pain medication</measure>
    <time_frame>2 years</time_frame>
    <safety_issue>No</safety_issue>
    <description>Documentation of drug related medication</description>
  </secondary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">32</enrollment>
  <condition>Degenerative Disc Disease</condition>
  <eligibility>
    <study_pop>
      <textblock>
        adult patients
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  all indications as given by the instructions for use

          -  Patients with persisting lumbosacral and pseudo-radicular pain scheduled for
             monosegmental lumbar interbody fusion from L4 to S1

          -  Age 18 - 60

          -  at least 6 months of unsuccessful treatment including conservative measures

          -  Non-sequestrated and subligamentous prolapse

        Exclusion Criteria:

          -  all contraindications, which are listed in the instructions for use.

          -  existing pregnancy, planned or occurring during study period

          -  patients with a higher degree of segmental degeneration in other than the segment to
             be operated

          -  body- mass-index (BMI) &gt; 30

          -  Systemic or local infection

          -  Increased risk of osteoporosis according to assessment by the SCORE evaluation

          -  Bone metabolism disorders

          -  Chemotherapy or radiotherapy (ongoing or planned)

          -  Participation in another clinical trial

          -  Scheduled for spinal litigation

          -  Other serious conditions that hinder the participation in the study

          -  Nanogel® filling of the cage, prior to implantation was not done
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Peter Douglas Klassen, MD (PY)</last_name>
    <role>Principal Investigator</role>
    <affiliation>St. Bonifatius Hospital Lingen</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Andrea Weiler, Dr.</last_name>
    <phone>+49-7461-95-2721</phone>
    <email>andrea.weiler@aesculap.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Norbert Pfeiff</last_name>
    <phone>+49-7461-95-1663</phone>
    <email>norbert.pfeiff@aesculap.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sana Kliniken Sommerfeld</name>
      <address>
        <city>Kremmen</city>
        <zip>16766</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <investigator>
      <last_name>Stefan Nikolaus Kroppenstedt, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>St. Bonifatius Hospital Lingen</name>
      <address>
        <city>Lingen</city>
        <zip>49808</zip>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Edelgard Klassen</last_name>
    </contact>
    <contact_backup>
      <last_name>Norbert Pfeiff</last_name>
    </contact_backup>
    <investigator>
      <last_name>Peter Douglas Klassen, MD (PY)</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 15, 2014</lastchanged_date>
  <firstreceived_date>July 5, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Intervertebral Disk Degeneration</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
